Colchicine for treatment of acute or recurrent pericarditis

Affiliations

¹ Département Hospitalo-Universitaire I2B, UPMC Univ Paris 06, UMR 7211, F-75005 Paris, France; INSERM, UMR_S 959, Paris, France; CNRS, UMR 7211, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine, Paris, France. Electronic address: patrice.cacoub@psl.aphp.fr.

Comment

Patrice P Cacoub. Lancet. 2014.

. 2014 Jun 28;383(9936):2193-4.

doi: 10.1016/S0140-6736(14)60113-6. Epub 2014 Mar 30.

¹ Département Hospitalo-Universitaire I2B, UPMC Univ Paris 06, UMR 7211, F-75005 Paris, France; INSERM, UMR_S 959, Paris, France; CNRS, UMR 7211, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine, Paris, France. Electronic address: patrice.cacoub@psl.aphp.fr.

No abstract available

Comment on

Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.
Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F, Demarie D, Ferro S, Forno D, Maestroni S, Cumetti D, Varbella F, Trinchero R, Spodick DH, Adler Y. Imazio M, et al. Lancet. 2014 Jun 28;383(9936):2232-7. doi: 10.1016/S0140-6736(13)62709-9. Epub 2014 Mar 30. Lancet. 2014. PMID: 24694983 Clinical Trial.